Me filed for bankruptcy on Sunday, hit by faltering demand for its ancestry testing kits as it struggled to contain the ...

A fledgling open source startup that's setting out to tackle API sprawl in the GraphQL ecosystem has secured the backing of e ...

Diagnostics' Q4 2024 earnings insights, FDA resubmissions, TB & HPV test pipelines, and international market growth plans.

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

For Larry Fitzgibbon, the St. Louis native who sold his company earlier this month for a reported $90 million, it all goes ...

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, named its new Board of Directors led by co-founder Jérôme Koch, in line with recent bridge financing organized ...

Me co-founder Linda Avey expressed frustration about the fall of the genetics testing company in a social media post.

Me has filed for Chapter 11 bankruptcy protection and its co-founder and CEO Anne Wojcicki has resigned as the company ...

Me Holding Co.’s stock tumbled 47% Monday, after the DNA-testing company filed for Chapter 11 bankruptcy, just months after ...

The company said it will look to sell “substantially all of its assets” through a court-approved reorganization plan.

Revenge of the Savage Planet promises to be a gloriously silly co-op adventure: "We wanted to make was just a game that ...